1.
Ahmed NJ. Drug-Induced Insomnia: Descriptive analysis of FDA Adverse Event Reporting System. AJP [Internet]. 2022 Sep. 15 [cited 2022 Dec. 10];16(3). Available from: https://asiapharmaceutics.info/index.php/ajp/article/view/4489